Type 2 Diabetes and Cardiovascular Disease
Slides (curriculum) - Sep. 5, 2015A slide lecture program in 4 modules, with over 180 PPt slides with a focus on approaches to manage CV risk in patients with T2D
A slide lecture program on glucose lowering agents on CV risk, like: DPP4 inhibitors, GLP1 agonists, SGLT2 inhibitors
A slide lecture program on type 2 diabetes, the pathophysiology, T2DM as CV risk factor & additional risk factors
Approaches to managing CV risk in patients with T2D
A slide lecture program on type 2 diabetes, glycaemic control, weight loss, control of dyslipidaemia & multifactorial approach to reducing CV events in T2DM
Evidence for effects of older glucose-lowering agents on CV risk
A slide lecture program on glucose lowering agents on CV risk, like: metformin, sulphonylureas, TZDs, and a rationale for FDA guidance
Share this page with your colleagues and friends: